overall survival data of the monarch-2 trial in hr /her2- breast cancer
Published 4 years ago • 286 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
5:34
monarch 2: overall survival of abemaciclib plus fulvestrant in hr , her2- advanced breast cancer
-
8:39
final overall survival analysis of monarch 1
-
1:13
significance of the monarch 2 findings for abemaciclib in hr /her2- breast cancer
-
4:38
monarch 2: overall survival results from abermaciclib plus fulvestrant in hr her2- advanced bre...
-
2:58
dr. goetz discusses a secondary analysis of the monarch trials in breast cancer
-
4:11
what is her2 positive breast cancer? | treatment/therapies for her2 positive breast cancer
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
1:54
cell cycle inhibitors - cdk4/6 inhibitors
-
5:12
monarch 2: abemaciclib added to fulvestrant shows os benefit in hr /her2- advanced breast cancer
-
5:06
safety outcomes in the phase iii monarche trial of abemaciclib et in hr , her2- breast cancer
-
2:26
updated results of the monaleesa-2 trial in hr /her2- breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
5:16
cdk4/6 inhibitor abemaciclib plus fulvestrant improves overall survival in hr-positive/her2-nega...
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
2:23
an overview of the neomonarch trial in hr /her2- breast cancer
-
2:20
an overview of the monarch and neomonarch trials in breast cancer
-
4:02
monarch-2 trial
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
0:34
george sledge, md, shares the most relevant findings from the monarch-2 trial
-
6:44
overall survival (os) results of the phase iii monaleesa-3 trial
-
2:42
phase ii results for abemaciclib in pretreated hr /her2-negative breast cancer
-
1:57
monarcher: final os results of abemaciclib in hr , her breast cancer